44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Microbiology and Biotechnology Reports

Sign up for email alert when new content gets added: Sign up

Time to stop using immunosuppressive agents in chronic glomerulonephritis

Author(s): Usama AA Sharaf El Din*, Mona M Salem and Dina O Abdulazim

Chronic glomerulonephritis is the third most important cause of end stage renal disease worldwide. Most of the patients suffering different types of glomerulonephritis are prescribed different immunosuppressive agents aiming at complete or partial remission in order to stop or muffle the progression of chronic kidney disease. Although the initial injury in case of glomerulonephritis is the glomerulus, the best predictor of renal survival is the amount of tubulointerstitial fibrosis. Recent trials have proved the efficacy of the anti-diabetic sodium glucose cotransporters-2 inhibitors in non-diabetic chronic kidney disease to significantly decrease the renal end points. Chronic glomerulonephritis represented a considerable bulk of nondiabetic cases recruited in these studies. This success should stimulate clinical Nephrologists to consider these agents in the newly diagnosed cases suffering increased urine protein excretion instead of immunosppressive treatment. In this review we will try to elucidate the value of these agents in management of patients presenting with different types of chronic glomerulonephritis

Full-Text | PDF

Recommended Conferences

26th World Congress on Biotechnology

Prague, Czech Republic

37th International Conference on Immunology

Vienna, Austria

14th World Congress on Cell & Tissue Science

Rome, Italy
Journal of Microbiology and Biotechnology Reports peer review process verified at publons
Global Tech Summit Top